Publications

(Displaying in Reverse Chronological Order)

  1. Research
  2. Publications
  3. Publications
1801
Guchhait SK, Madaan C and Thakkar BS. A highly flexible and efficient Ugi-type multicomponent synthesis of versatile N-fused aminoimidazoles Synthesis 2009, 19, 3293-3300.
1802
Gupta A and Dey CS. PTEN and SHIP2 regulates PI3K/Akt pathway through focal adhesion kinase Molecular and Cellular Endocrinology 2009, 309, 55-62.
1803
Gupta A, Mehra P, Deshmukh A, Dar A, Mitra P, Roy N and Dhar SK. Functional dissection of the catalytic carboxyl-terminal domain of origin recognition complex subunit 1 (PfORC1) of the human malaria parasite Plasmodium falciparum Eukaryot Cell 2009, 8, 1341-1351.
1804
Gupta H, Bhatnagar A, Mittal G, Malik A and Jain S. Development and characterization of 99mTc-timolol maleate for evaluating efficacy of in situ ocular drug delivery system AAPS PharmSciTech 2009, 10, 540-546.
1805
Gupta P, Roy N and Garg P. Docking-based 3D-QSAR study of HIV-1 integrase inhibitors European Journal of Medicinal Chemistry 2009, 44, 4276-4287.
1806
Hiwale PB, Amin A, Patel S and Bansal AK. Variables affecting reconstitution behaviour of cefuroxime sodium for injection Asian Journal of Pharmaceutical Sciences 2009, 4, 23-31.
1807
Italia JL, Singh D and Ravi Kumar MNV. High-performance liquid chromatographic analysis of amphotericin B in rat plasma using alpha-naphthol as an internal standard Analytica Chimica Acta 2009, 634, 110-114.
1808
Jain D, Roy N and Chattopadhyay D. CaZF, a plant transcription factor functions through and parallel to HOG and calcineurin pathways in Saccharomyces cerevisiae to provide osmotolerance PLoS One 2009, 4, (e5154) .
1809
Jain P, Jain S, Prasad KN, Jain SK and Vyas SP. Polyelectrolyte Coated Multilayered Liposomes (Nanocapsules) for the Treatment of Helicobacter pylori Infection Molecular Pharmaceutics 2009, 6, 593-603.
1810
Jhamb SS and Singh PP. A short-term model for preliminary screening of potential anti-tubercular compounds Scandinavian Journal of Infectious Diseases 2009, 41, 886-889.
1811
Kabra DG, Gupta J and Tikoo K. Insulin induced alteration in post-translational modifications of histone H3 under a hyperglycemic condition in L6 skeletal muscle myoblasts Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2009, 1792, 574-583.
1812
Kalaria DR, Sharma G, Beniwal V and Kumar Ravi MN. Design of Biodegradable Nanoparticles for Oral Delivery of Doxorubicin: In vivo Pharmacokinetics and Toxicity Studies in Rats Pharmaceutical Research 2009, 26, 492-501.
1813
Kansal H and Banerjee UC. Enhancing the biocatalytic potential of carbonyl reductase of Candida viswanathii using aqueous-organic solvent system Bioresource Technology 2009, 100, 1041-1047.
1814
Kaundal RK, Iyer S, Kumar A and Sharma SS. Protective effects of pioglitazone against global cerebral ischemic-reperfusion injury in gerbils Journal of Pharmacological Sciences 2009, 109, 361-367.
1815
Kaur S and Bhutani KK. In vitro Propagation of Vanda testacea ( Lindl.) reichb.f. - A Rare Orchid of High Medicinal Value Plant Plant Tissue Culture and Biotechnology 2009, 19, 7-1.
1816
Kaur S, Patel H, Sharma V, Garg P and Roy N. LeishBase: Leishmania major structural database International Journal of Integrative Biology 2009, 7, 63-68.
1817
Kharatmal S, Jhamb SS and Singh PP. Evaluation of BACTEC 460 TB system for rapid in vitro screening of drugs against latent state Mycobacterium tuberculosis H37Rv under hypoxia conditions Journal of Microbiological Methods 2009, 78, 161-164.
1818
Kumar P, Kaundal RK, More S and Sharma SS. Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease Behavioural Brain Research 2009, 197, 398-403.
1819
Kumar V, Shah RP, Malik S and Singh S. Compatibility of atenolol with excipients: LC-MS/TOF characterization of degradation/interaction products, and mechanisms of their formation Journal of Pharmaceutical and Biomedical Analysis 2009, 49, 880-888.
1820
Lal UR, Tripathi SM, Jachak SM, Bhutani KK and Singh IP. HPLC analysis and standardization of Arjunarishta - An Ayurvedic cardioprotective formulation Scientia Pharmaceutica 2009, 77, 605-616.
1821
Latha S, Selvamani P, Kumar CS, Sharavanan P, Suganya G, Beniwal VS and Ramarao P. Formulation development and evaluation of metronidazole magnetic nanosuspension as a magnetic targeted and polymeric controlled drug delivery system Journal of Magnetism and Magnetic Materials 2009, 321, 1580-1585.
1822
Limbachiya MS and Pande AH. Peptide derived from the lipid binding domain of Group IB human pancreatic phospholipase A2 possesses antibacterial activity Biochimie 2009, 91, 1387-1393.
1823
Malik S and Kartha KPR. A mild, highly efficient, and chemoselective deprotection of trityl ethers of carbohydrates and nucleosides using iodine monobromide Synlett 2009, 2009, 1809-1811.
1824
Mandavi, Padmavathi R, Rohit M, Tiwari P and Kapur V. Impact on the outcome of pharmacotherapy of senior Indian inpatients: A pharmacist led intervention Indian Journal of Pharmacy Practice 2009, 2, 31-37.
1825
Mittal G and Ravi Kumar MNV. Impact of polymeric nanoparticles on oral pharmacokinetics: A dose-dependent case study with estradiol Journal of Pharmaceutical Sciences 2009, 98, 3730-3734.
1826
Mittal G, Chandraiah G, Ramarao P, Kumar Ravi MNV. Pharmacodynamic Evaluation of Oral Estradiol Nanoparticles in Estrogen Deficient (Ovariectomized) High-Fat Diet Induced Hyperlipidemic Rat Model Pharmaceutical research 2009, 26, 218-223.
1827
Mittal N, Babu MM and Roy N. The efficiency of mitochondrial electron transport chain is increased in the long-lived mrg19 Saccharomyces cerevisiae Aging Cell 2009, 8, 643-653.
1828
Mittal N, Roy N, Babu MM and Janga SC. Dissecting the expression dynamics of RNA-binding proteins in post-transcriptional regulatory networks PNAS 2009, 106, 20300-20305.
1829
Moon LS, Jolly RS, Kasetti Y and Bharatam PV. A New Chiral Shift Reagent for Determination of Enantiomeric Excess and Absolute Configuration of Cyanohydrins Chemical Communications 2009, 0, 1067-1069.
1830
Mugunthan G and Kartha KPR. Carbohydrates and Nucleoside chemistry by ball milling Trends in Carbohydrates Chemistry 2009, 1, 9-1.
1831
Nayyar A, Patel SR, Shaikh M, Coutinho E and Jain R. Synthesis, anti-tuberculosis activity and 3D-QSAR study of amino acid conjugates of 4-(adamantan-1-yl) group containing quinolines European Journal of Medicinal Chemistry 2009, 44, 2017-2029.
1832
Okner R, Oron M, Tal N, Nyska A, Kumar N, Mandler D and Domb AJ. Electrocoating of stainless steel coronary stents for extended release of paclitaxel Journal of Biomedical Materials Research 2009, 88, 427-436.
1833
Padmanabhan S, Tripathi DN, Vikram A, Ramarao P and Jena GB. Methotrexate-induced cytotoxicity and genotoxicity in germ cells of mice: Intervention of folic and folinic acid Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2009, 673, 43-52.
1834
Pande AH and Tripathy RK. Preferential binding of apolipoprotein E derived peptides with oxidized phospholipid Biochemical and Biophysical Research Communications 2009, 380, 71-75.
1835
Pande AH, Tripathy RK and Nankar SA. Membrane surface charge modulates lipoprotein complex forming capability of peptides derived from the C-terminal domain of apolipoprotein E Biochimica et Biophysica Acta (BBA) - Biomembranes 2009, 1788, 1366-1376.
1836
Patel DS and Bharatam PV. Novel (+)N(?L)2 species with two lone pairs on nitrogen: systems isoelectronic to carbodicarbenes Chemical Communications 2009, 0, 1064-1066.
1837
Patil PR and Kartha KPR. Solvent-free synthesis of thioglycosides by ball milling Green Chemistry 2009, 11, 953-956.
1838
Pawar AA, Vikram A, Tripathi DN, Padmanabhan S, Ramarao P and Jena GB. Modulation of Mitomycin C Induced Genotoxicity by Acetyl- and Thio- Analogue of Salicylic acid In Vivo 2009, 23, 303-307.
1839
Prasad B and Singh S. In vitro and in vivo investigation of metabolic fate of rifampicin using an optimized sample preparation approach and modern tools of liquid chromatography-mass spectrometry Journal of Pharmaceutical and Biomedical Analysis 2009, 50, 475-490.
1840
Rajic Z, Kos G, Zorc B, Singh PP and Singh S. Macromolecular prodrugs. XII. Primaquine conjugates: synthesis and preliminary antimalarial evaluation Acta Pharmaceutica 2009, 59, 107-115.
1841
Rajput SK, Krishnamoorthy S, Pawar C, Kaur N, Monga V, Meena CL, Jain R and Sharma SS. Antiepileptic potential and behavioral profile of l-pGlu-(2-propyl)-l-His-l-ProNH2, a newer thyrotropin-releasing hormone analog Epilepsy & Behavior 2009, 14, 48-53.
1842
Rajput SK, Singh JN, Ingole S, Jain G, Kaur N, Monga V, Meena CL, Jain R and Sharma SS. Neuropharmacological profile of L-pGlu-(1-benzyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone analog: effects on seizure models, sodium current, cerebral blood flow and behavioral parameters Epilepsy Research 2009, 87, 223-233.
1843
Ratnam DV, Chandraiah G, Meena AK, Ramarao P, Ravi Kumar MNV. The Co-Encapsulated Antioxidant Nanoparticles of Ellagic Acid and Coenzyme Q10 Ameliorates Hyperlipidemia in High Fat Diet Fed Rats Journal of nanoscience and nanotechnology 2009, 9, 6741-6746.
1844
Saandeep K, Vikram A, Tripathi DN, Ramarao P and Jena GB. Influence of Hyperglycaemia on Chemical-Induced Toxicity: Study with Cyclophosphamide in Rat Basic & Clinical Pharmacology & Toxicology 2009, 105, 236-242.
1845
Savaliya AA, Prasad B, Raijada DK and Singh S. Detection and characterization of synthetic steroidal and non-steroidal anti-inflammatory drugs in Indian ayurvedic/herbal products using LC-MS/TOF Drug Testing and Analysis 2009, 1, 372-381.

Information: Duration to be uploaded/incorporated on archival site after the completion of process is 12 months.

2627|41|45